Rising FDA approval to Propel the North American Actinic Keratosis Treatment Market

North American actinic keratosis treatment market is anticipated to exhibit a moderate CAGR during the forecast period (2020-2026). The rising FDA approval of treatment options for actinic keratosis is anticipated to drive the growth of the regional market. Cumulative sun exposure is the single most important cause of actinic keratosis. According to the American Academy of Dermatology Association, it is estimated that more than 40 million Americans develop actinic keratoses each year in the US. The high prevalence of actinic keratosis in the region creates a huge demand for therapies and medications for its treatment. 

Browse the full report description North American Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report by Type (Medication, Therapy, Other), and By End-User (Hospitals & Oncology Centers, Dermatology Clinics) Forecast period (2020-2026) at https://www.omrglobal.com/industry-reports/north-american-actinic-keratosis-treatment-market

Looking towards the rising demand for actinic keratosis treatments several players are launching new Actinic Keratosis Treatments in the market. For instance, in March 2020, Almirall, S.A. had announced that the US FDA has completed its filing review and determined that the New Drug Application (NDA) for tirbanibulin, also known as ALM147891, for the treatment of actinic keratosis is sufficiently complete to permit a substantive review. The FDA’s acceptance for filing of the NDA of tirbanibulin, following the acceptance for filing by the EMA, demonstrates a significant step towards its approval both in the US and Europe. 

Market Coverage

• The market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Type, End-User
• Regions Covered- North America
• Competitive Landscape- Bausch Health Companies Inc., Cipher Pharmaceuticals Inc., Hill Dermaceuticals, Inc., Stanford Chemicals Company, Valeant Pharmaceuticals Inc., and so on. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from the pre-COVID-19 forecast

o Most affected region/segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

North American Actinic Keratosis Treatment Market Report Segment

By Type

• Medication
• Therapy
• Others

By End-User

• Hospitals & Oncology Centers
• Dermatology Clinics

North American Actinic Keratosis Treatment Market Report Segment

• United States
• Canada